'Catheter ablation' presentation slideshows

Tachydysrrhythmias

Tachydysrrhythmias. Lisa Campfens MD, FRCPC, FACEP. Generation of Dysrrhythmias. Two fundamental causes Disturbances of automaticity Disturbances of conduction AV block Reentry. Presentation. Multiple symptoms: Fatigue Chest pain Dyspnea Dizziness Presyncope Palpitations

816 views • 66 slides

Arrhythmias in the elderly Something old, something new?

836 views • 52 slides

Heart Rhythm 2012

Heart Rhythm 2012. Nick Jackson. Boston. The 23 versus the 28mm cryoballoon. We followed 200 consecutive patients with paroxysmal (139 patients) and persistent AF (61 patients) for a median of 482 (20-1095) days following cryoballoon ablation.

557 views • 47 slides

La gestione della fibrillazione atriale nel paziente con insufficienza cardiaca:

647 views • 43 slides

Stepwise ????????????????

606 views • 34 slides

Sleep Apnea

Sleep Apnea. And Conditions seen in the ICU. Sleep Basics. Some Definitions. Obstructive Sleep Apnea OSA Central Sleep Apnea CSA Excess D aytime Somnolence EDS Polysomnography PSG (Sleep Study) Continuous Positive Airway Pressure CPAP

742 views • 33 slides

Advancing patient care with NOACs in other cardiac interventions

331 views • 33 slides

Disclosures*

246 views • 24 slides

Lucas Boersma, WimJan van Boven, Alaaddin Yilmaz, Johannes Kelder, Maurits Wijffels

Atrial F ibrillation Catheter A blation versus S urgical Ablation T reatment: FAST A Two-Center Randomized Clinical Trial. Lucas Boersma, WimJan van Boven, Alaaddin Yilmaz, Johannes Kelder, Maurits Wijffels Cardiology&Cardiac Surgery Dept, St.Antonius Hospital, Nieuwegein, Netherlands

359 views • 17 slides

Atrial Fibrillation Ablation Market Size 2022

Rise in prevalence rate of atrial fibrillation in geriatric population, technological advancements in devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures, and increase in patient awareness propel the market growth. However, dearth of skilled professionals and unfavorable preference to pharmaceutical drugs hamper the growth of the market.Catheter ablation is the highest revenue contributor and is expected to grow at the highest CAGR of 13.8% in the analysis period. This growth is owing to the technological advancements such as cryoFORM, which offers increased flexibility that allows easy manipulation and treatment during surgical process. Read more details at: https://www.alliedmarketresearch.com/atrial-fibrillation-market

356 views • 13 slides

The Feasibility and Efficacy of Ablation of Paroxysmal Atrial Fibrillation Using Different Technologies

This analysis assesses the efficacy of ablation of paroxysmal atrial fibrillation (PAF). Methods: We studied 150 patients (pts). 40 pts underwent manual radio frequency (RF) ablation using CARTO, 40 pts underwent ablation using NavX system, 70 pts underwent robotic ablation. The success rate for the robotic group was 92.4%. The manually treated group (Carto and NavX) has a success rate of 88.5%.

89 views • 8 slides

Atrial Fibrillation Surgery Market expected worth $1.73 Billion by 2020

the global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020.

111 views • 7 slides

203 views • 6 slides

Atrial Fibrillation Market Worth USD 16.2 Billion by 2020 | Hexa Research

The increasing incidences of atrial fibrillation, strokes due to blood clots and brain damages are the major factors driving the global atrial fibrillation market.

138 views • 6 slides

Atrial fibrillation is an irregular heartbeat or arrhythmia that can lead to blood clots or other conditions. The article discusses the condition in detail along with the medical codes.

61 views • 6 slides

Atrial Fibrillation Market Is Expected To Reach USD 16.17 Billion by 2020

Asia Pacific is expected to register the highest CAGR of 15.3% during the forecast period. Growing demand for non-pharmacological treatments on account of constantly improving healthcare infrastructure, patient awareness and disposable income levels are some of the factors accounting for its rapid growth.

192 views • 4 slides

Atrial Fibrillation Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart.

46 views • 4 slides

The Middle East and Africa Atrial Fibrillation Surgery Market is expected to grow at a CAGR of 16.2%, to reach USD 0.24

Atrial Fibrillation is an abnormal rhythm or quivering of the heart caused by irregular beating of the atria. This condition of heart can lead to stroke, blood clots, heart failure and other heart related issues. The symptoms include fainting, chest pain, shortness of breath and heart palpitations.

34 views • 3 slides

VTACH

VTACH. Median time to recurrence of VT: 18.6 months with catheter ablation vs. 5.9 months with control 24-month freedom from VT: 47% vs. 29%, respectively Mean appropriate shocks per patient per year: 0.6 vs. 3.4 (p = 0.018), respectively.

252 views • 1 slides